Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
352.72
+9.16 (2.67%)
May 26, 2026, 1:34 PM EDT - Market open
PRAX Market Cap
PRAX has a market cap or net worth of $9.83 billion as of May 26, 2026. Its market cap has increased by 1,168.43% in one year.
Market Cap
9.83B
Enterprise Value
8.45B
1-Year Change
1,168.43%
Ranking
Category
Stock Price
$352.72
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $9.83B, an increase of 1,308.75%. That is a compound annual growth rate of 60.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 9.58B | 29.95% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 12.14B |
| Madrigal Pharmaceuticals | 11.93B |
| ABIVAX Société Anonyme | 10.68B |
| Arrowhead Pharmaceuticals | 10.56B |
| BioMarin Pharmaceutical | 10.45B |
| Cytokinetics | 10.45B |
| Krystal Biotech | 8.83B |
| Halozyme Therapeutics | 8.10B |